Weight Loss Market
Aug 02, 2024
WEGOVY: A Leader in the Obesity and Weight Loss Treatment
With the growing global health concern regarding obesity, Novo’s WEGOVY (semaglutide) has emerged as a leading solution in the weight loss treatment market. WEGOVY is a GLP-1 receptor agonist used alongside a low-calorie diet and increased physical activity. This obesity medication is administered as a weekly subcu...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
